Citius Pharmaceuticals Inc
(STU:47N0)
€
3.29
(0%)
Market Cap: 16.25 Mil
Enterprise Value: 19.52 Mil
PE Ratio: 0
PB Ratio: 0.23
GF Score: 25/100 Citius Pharmaceuticals Inc at Benzinga Virtual Global Small Cap Conference Transcript
May 13, 2021 / 05:50PM GMT
Release Date Price:
€41.25
(-7.82%)
Spencer Israel
Benzinga - Executive Producer, BenzingaTV
All right. Let's put on our next speaker here. Myron Holubiak is the President and CEO at Citius Pharmaceuticals. If the chat -- if social media chat is any indication, we seem to have a lot of people that are very interested in this company.
So, Myron, good afternoon. Good to see you.
Myron Holubiak
Citius Pharmaceuticals, Inc. - President & CEO
Good to see you, Spencer. Good catching up with you too.
Spencer Israel
Benzinga - Executive Producer, BenzingaTV
Yes, good catching up. All right. Let's go ahead and share your screen. I see it up there. There we go. I'm going to turn the floor over to you. Tell us about Citius.
Myron Holubiak
Citius Pharmaceuticals, Inc. - President & CEO
Thanks, Spencer. Thanks very much. I'll put up the standard disclaimer statement, but there's -- as you know, I've highlighted some things. So please, if anybody is interested in investing in Citius, we strongly
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot